47.73.Z - Retail sale of pharmaceutical products
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
47.78.Z - Retail sale of other new products
2021 | 2022 | 2023 | ||
---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Gross profit (loss) | -4,4 | -4,9 | -5,5 | -10,9 |
EBITDA | -3,9 | -4,4 | -4,7 | -7,5 |
Short time liabilities | 0,4 | 0,5 | 0,5 | -3,3 |
Equity capital | -7,9 | -12,8 | -18,2 | -42,8 |
Operating profit (EBIT) | -3,9 | -4,4 | -4,7 | -7,5 |
Assets | 10,3 | 6 | 5,6 | -7,7 |
Net profit (loss) | -4,4 | -4,9 | -5,5 | -10,9 |
Cash | 6,1 | 1,2 | 0,2 | -86,2 |
Net income from sale | 0 | 0 | 0 | 0 |
Liabilities and provisions for liabilities | 18,2 | 18,8 | 23,8 | 26,5 |
Working assets | 10,2 | 5,9 | 5,5 | -7,8 |
Depreciation | 0 | 0 | 0 | 0 |
% | % | % | p.p. | |
Profitability of capital | 56,2 | 38,5 | 29,9 | -8,6 |
Equity capital to total assets | -76 | -211,3 | -326,8 | -115,5 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 2 147 483 648 | 2 147 483 648 | 2 147 483 648 | 0 |
Current financial liquidity indicator | 24.10321617126465 | 11.134125709533691 | 10.610028266906738 | -0,5 |
Net dept to EBITDA | -2.9969615936279297 | -3.8826701641082764 | -4.90260124206543 | -1 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane